Journal profile · MEDICINE, GENERAL & INTERNAL
Current Issues in Pharmacy and Medical Sciences
ISSN 2084-980X · eISSN 2300-6676 · Sciendo · Poland
Current Issues in Pharmacy and Medical Sciences: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 0.7 (journal website); fully open access; APC charged, amount not published; review about 16 weeks (community reports); 33 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Current Issues in Pharmacy and Medical Sciences is published by Sciendo and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Analytical Methods in Pharmaceuticals, Phytochemicals and Antioxidant Activities and Analytical Chemistry and Chromatography, together about 24.4% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
1. Aim and Scope Our mission is to advance scientific knowledge in pharmacy, medicine, dentistry, and health sciences through the publication of innovative, methodologically robust studies. To reflect the broad spectrum of biomedical research, the journal is organized into the following sections: Pharmaceutical Sciences – encompassing medicinal chemistry, pharmacology, pharmacognosy, pharmaceutical technology, biopharmacy, toxicology, and drug design. Medical Sciences – focusing on clinical and experimental medicine, translational research, diagnostics, and therapeutic strategies. Dentistry Sciences – dedicated to advances in dental materials, oral biology, clinical dentistry, maxillofacial research, and preventive oral health. Health Sciences – covering public health, epidemiology, health policy, nursing, physiotherapy, and medical education. Current Issues in Pharmacy and Medical Sciences welcomes original research articles, review papers, short communications, and case reports. We encourage submissions from both academic researchers and clinical practitioners, highlighting translational approaches that bridge experimental results and real-world medical applications. The journal supports the global exchange of scientific information and promotes open dialogue between scientists, clinicians, and healthcare professionals around the world. 2. Open Access Policy Current Issues in Pharmacy and Medical Sciences provides immediate open access to its content, supporting the principle that making research available to the public promotes a greater global exchange of knowledge.All articles published in the journal are freely available online without subscription or access fees. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of articles without asking prior permission from the publisher or the author, provided that the original work is properly cited. 3. Copyright and Licensing Authors retain the copyright to their work while granting the publisher the right to publish the article and identify itself as the original publisher.All articles in Current Issues in Pharmacy and Medical Sciences are distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (CC BY-NC-ND 4.0). This license permits users to copy and redistribute the material in any medium or format for non-commercial purposes, provided that proper attribution is given to the original authors and the source, and the mat
From the journal's Aims & Scope
Research area (LetPub): MEDICINE, GENERAL & INTERNAL
Editor-in-chief Mariola HerbetPublisher website
Editorial board by country: none in mainland China; most named Poland 12 (12 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Analytical Methods in PharmaceuticalsChemistry9.4%
- Phytochemicals and Antioxidant ActivitiesMedicine8.1%
- Analytical Chemistry and ChromatographyChemistry6.9%
- Essential Oils and Antimicrobial ActivityAgricultural and Biological Sciences5.8%
- Drug Solubulity and Delivery SystemsPharmacology, Toxicology and Pharmaceutics5.6%
- Pharmacological Effects of Natural CompoundsPharmacology, Toxicology and Pharmaceutics5.1%
- Natural product bioactivities and synthesisBiochemistry, Genetics and Molecular Biology4.8%
- Phytochemistry and Biological ActivitiesAgricultural and Biological Sciences3.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Medicine, General & Internal | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Medicine, General & Internal | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of ScienceEmbasePublisher website
Other: Openalex, Library of Science, Sudoc, TitleDoi, Wikidata, Zdb, ICI Journals Master List
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 0.7Publisher website ·
- CiteScore 2026-06
- 1.4LetPub ·
- CiteScore (publisher)
- 14Publisher website ·
- SJR 2026-06
- 0.22LetPub ·
- SNIP 2026-06
- 0.33LetPub ·
- SNIP (publisher)
- 0.33Publisher website ·
- h-index
- 17OpenAlex ·
- i10-index
- 59OpenAlex ·
- 2-year mean citedness
- 0.9OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 45LetPub ·
Articles by year OpenAlex count · 759 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 34 | 34 | 0 |
| 2025 | 33 | 33 | 18 |
| 2024 | 41 | 41 | 79 |
| 2023 | 41 | 41 | 91 |
| 2022 | 40 | 40 | 165 |
| 2021 | 42 | 42 | 128 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 16 weeksLetPub ·
- Submission to publication (journal-reported)
- about 16 weeksDOAJ ·
- Peer review
- Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | PLN 600 / EUR 135 | No | CC BY | |
| OpenAlex | EUR 90 / PLN 369 | — | — | |
| LetPub | PLN 369 / EUR 90 | No | — | |
| Publisher website | EUR 135 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websiteConflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Peer review, Plagiarism
- Conflicts of interest 7. Conflicts of Interest
Authors must disclose any financial or personal relationships that could inappropriately influence their work. All sources of funding and potential conflicts of interest must be clearly stated in the manuscript. If no conflicts exist, authors should include the following statement in their manuscript: "The authors declare no conflict of interest."
Source ↗Publisher website ·- Data availability 9. Data Availability
Authors are encouraged to make the data supporting the results of their research publicly available whenever possible. Data may be deposited in appropriate public repositories or provided as supplementary materials accompanying the article.
Source ↗Publisher website ·- Publication ethics 5. Publication Ethics and Malpractice Statement
The journal is committed to maintaining the highest standards of integrity in scholarly publishing. The editorial policies follow internationally recognized ethical guidelines, including those provided by the Committee on Publication Ethics (COPE). Editors, reviewers, and authors are expected to adhere to ethical standards including:
Source ↗Publisher website ·- License & copyright 3. Copyright and Licensing
Licensed under CC BY 4.0 (until May 22, 2026 CC-BY-NC-ND). Model summary
Authors retain the copyright to their work while granting the publisher the right to publish the article and identify itself as the original publisher.All articles in Current Issues in Pharmacy and Medical Sciences are distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (CC BY-NC-ND 4.0). This license permits users to copy and redistribute the materi…
Source ↗Publisher website ·- Open access 2. Open Access Policy
Current Issues in Pharmacy and Medical Sciences provides immediate open access to its content, supporting the principle that making research available to the public promotes a greater global exchange of knowledge.All articles published in the journal are freely available online without subscription or access fees. Users are allowed to read, download, copy, distribute, print, search, or link to the…
Source ↗Publisher website ·- Peer review 4. Peer Review Process
Peer-reviewed, open-access journal. Model summary
All submitted manuscripts undergo a rigorous peer review process. Following an initial editorial screening, manuscripts that meet the journal’s scope and basic quality requirements are sent to at least two independent reviewers who are experts in the relevant field. The journal applies a double-blind peer review process, in which both the reviewers and the authors remain anonymous throughout the r…
Source ↗Publisher website ·- Plagiarism 6. Plagiarism and Similarity Check Policy
All submitted manuscripts are screened for plagiarism and text similarity using professional plagiarism detection software. Manuscripts that contain evidence of plagiarism, redundant publication, or significant overlap with previously published material will be rejected (above 30% Similarity Check). The editorial office reserves the right to request clarification or supporting documentation from a…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Sciendo
- Country or region
- Poland
- Language
- English
- ISSN
- 2084-980X
- Electronic ISSN
- 2300-6676
- Latest issue on the website
- Volume 39, Issue 2 (2026)
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Current Issues in Pharmacy and Medical Sciences
What CAS zone is Current Issues in Pharmacy and Medical Sciences in?
In the 2025 upgraded edition of the CAS Journal Ranking, Current Issues in Pharmacy and Medical Sciences is in Zone 4 of Medicine, and in Zone 4 of the minor category Medicine, General & Internal. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Current Issues in Pharmacy and Medical Sciences?
The journal's website gives an impact factor of 0.7; this is the journal's own figure, as LetPub lists none for it; CiteScore 1.4, h-index 17.
How long does peer review take at Current Issues in Pharmacy and Medical Sciences?
Authors report an average review time of about 16 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Current Issues in Pharmacy and Medical Sciences based?
Of the 12 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Poland (12). Counted from the institutions listed on the board page; for reference only.
Which databases index Current Issues in Pharmacy and Medical Sciences?
According to LetPub and DOAJ records, Current Issues in Pharmacy and Medical Sciences is indexed in ESCI, Scopus and DOAJ. The journal's website also lists Web of Science and Embase; that list has not been checked against each database.
Is Current Issues in Pharmacy and Medical Sciences open access, and what is the APC?
Current Issues in Pharmacy and Medical Sciences is a fully open-access journal. APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .